Share this article and save a life!
One AI model just beat every specialist radiologist AI.
And it might change how we think about medical AI forever.
Published March 5 in NEJM AI, MedVersa’s generalist model didn’t just compete with specialist systems, it matched or exceeded them across report generation, segmentation, detection, and visual question-answering tasks.
Here’s what makes this groundbreaking:
Specialist AI models are trained for one thing: chest X-rays, brain MRIs, mammograms. We’ve invested billions building separate tools for each imaging type.
But MedVersa proves a single model can do it all.
📊 The implications are massive:
• Lower implementation costs (one system vs. dozens)
• Simplified workflows for radiologists
• Faster deployment across health systems
• Better cross-modality pattern recognition
Think about what this means for community hospitals and FQHCs.
Instead of choosing between a lung nodule detector or a stroke identifier because of budget constraints, they get both. And more.
The model also boosted radiologist workflow efficiency in real-world testing. Not just accuracy, but speed.
But here’s the question nobody’s asking:
If one AI can master all of radiology, what happens to the dozens of specialized AI companies? Do we need 50 different chest X-ray algorithms when one generalist performs better?
This isn’t just about technology. It’s about access.
Smaller facilities that couldn’t afford multiple specialist AIs now have a path to world-class diagnostic support. One subscription, comprehensive coverage.
The specialist vs. generalist debate in medicine just got turned on its head.
Maybe the future isn’t hyperspecialization. Maybe it’s intelligent versatility.
♻️ Repost if generalist AI could democratize advanced diagnostics
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
